FDA Issues Nationwide Recall of Levothyroxine Batches Over Potential Under-Potency Concerns

A selective recall of levothyroxine sodium tablets has been announced by U.S. regulators after testing revealed certain lots may contain lower concentrations of the active ingredient than labeled, prompting fresh concerns among the millions of Americans who rely on the…













